Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence

Publisher： John Wiley & Sons Inc

E-ISSN： 1751-2980|18|11|607-617

ISSN： 1751-2972

Source： Journal of Digestive Diseases, Vol.18, Iss.11, 2017-11, pp. : 607-617

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for non-alcoholic steatohepatitis

By Tomeno Wataru   Yoneda Masato   Imajo Kento   Ogawa Yuji   Kessoku Takaomi   Saito Satoru   Eguchi Yuichiro   Nakajima Atsushi  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 3, 2013-09 ,pp. : 279-290

Informa Healthcare

Access to resources Recommend Favorite

Evolving therapies for non-alcoholic steatohepatitis

By Tilg Herbert   Moschen Alexander R  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 6, 2014-06 ,pp. : 687-696

Informa Healthcare

Access to resources Recommend Favorite

Cyclophosphamide/dexamethasone: Non-alcoholic steatohepatitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1233, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Betaine hydrochloride shows promise for treatment of nonalcoholic steatohepatitis

By  

Inpharma, Vol. 1, Iss. 1311, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Role of microRNAs in Non-Alcoholic Steatohepatitis

By  

Current Pharmaceutical Design, Vol. 16, Iss. 17, 2010-06 ,pp. : 1952-1957

Bentham Science Publishers

Access to resources Recommend Favorite